Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease
Journal of Veterinary Internal Medicine2017Vol. 31(3), pp. 791–798
Citations Over TimeTop 10% of 2017 papers
Valerie J. Parker, Laura M. Harjes, Katarzyna Dembek, Gregory Young, Dennis J. Chew, Ramiro E. Toribio
Abstract
CKD in dogs is associated with decreases in all vitamin D metabolites evaluated suggesting that multiple mechanisms, in addition to decreased renal mass, affect their metabolism. This information could have prognostic and therapeutic implications.
Related Papers
- → Persistent fibroblast growth factor 23 signalling in the parathyroid glands for secondary hyperparathyroidism in mice with chronic kidney disease(2017)64 cited
- → Extended-release calcifediol for secondary hyperparathyroidism in stage 3-4 chronic kidney disease(2017)35 cited
- → Calcifediol to treat secondary hyperparathyroidism in patients with chronic kidney disease(2017)14 cited
- → Relationship of associated secondary hyperparathyroidism to serum fibroblast growth factor-23 in end stage renal disease: A case-control study(2011)35 cited
- → Diagnostic utility of FGF-23 in mineral bone disorder during chronic kidney disease(2022)8 cited